Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
© 2020, The Author(s), under exclusive licence to Springer Nature America, Inc. Approximately 20-30% of human lung adenocarcinomas (LUADs) harbor mutations in Kelch-like ECH-associated protein 1 (KEAP1) that hyperactivate the nuclear factor, erythroid 2-like 2 (NFE2L2) antioxidant program. We previo...
Main Authors: | Romero, Rodrigo (Author), Sánchez-Rivera, Francisco J (Author), Westcott, Peter MK (Author), Mercer, Kim L (Author), Bhutkar, Arjun (Author), Muir, Alexander (Author), González Robles, Tania J (Author), Lamboy Rodríguez, Swanny (Author), Liao, Laura Z (Author), Ng, Sheng Rong (Author), Li, Leanne (Author), Colón, Caterina I (Author), Naranjo, Santiago (Author), Beytagh, Mary Clare (Author), Lewis, Caroline A (Author), Hsu, Peggy P (Author), Bronson, Roderick T (Author), Vander Heiden, Matthew G (Author), Jacks, Tyler (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media LLC,
2021-10-25T18:57:39Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
by: Sayin, Volkan I., et al.
Published: (2018) -
Epigenetic Regulation of NRF2/KEAP1 by Phytochemicals
by: Shamee Bhattacharjee, et al.
Published: (2020-09-01) -
Generation and characterization of keap1a- and keap1b-knockout zebrafish
by: Vu Thanh Nguyen, et al.
Published: (2020-09-01) -
Isoform-specific deletion of PKM2 constrains tumor initiation in a mouse model of soft tissue sarcoma
by: Talya L. Dayton, et al.
Published: (2018-05-01) -
The KEAP1–NRF2 System in Cancer
by: Keiko Taguchi, et al.
Published: (2017-05-01)